New joy of cardiac disease

Similar documents
Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals

Emerging Cardiac Technologies. Thomas D. Conley, MD FACC FSCAI BHHI Primary Care Symposium February 27, 2015

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

Absorbable Scaffolds the Future of Coronary Interventions?

Current Status of BioresorbableScaffolds: Moving Forward or Backwards?

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program

Catheter-based mitral valve repair MitraClip System

DISAPPEARING STENT: IS THE TIME APPEARED?

Bioresorbable stents for all or for few? Franz-Josef Neumann

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

UnitedHealthcare, UnitedHealthcare of the River Valley and Neighborhood Health Partnership Cardiology Notification and Prior Authorization Program:

Pushing the limits of cardiac CT. Steven Dymarkowski Radiology / Medical Imaging Research Centre

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium

Stephen G. Ellis, M.D. Professor of Medicine Director Invasive Services Co-Director Cardiac Gene Bank

New Cardiac Technologies. Melva Meminger MSN, RN, CCRN

Nobori Clinical Studies Up-dates. Gian Battista DANZI, M.D. Ospedale Maggiore Policlinico University of Milan, Italy

Understanding the guidelines for Interventions in MR. Ali AlMasood

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas

Optical Coherence Tomography

Percutaneous Mitral Valve Repair

Introducing the COAPT Trial

Mitral Regurgitation

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

EluNIR. Ridaforolimus Eluting Coronary Stent System. Advancing Deliverability for the Road Ahead

Prognostic Impact of FMR

Cover Page. Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence tomography Issue Date:

Your heart is a muscular pump about the size of your fist, located

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Valvular Intervention

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Percutaneous Repair for MR:

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?

Adult Cardiology Clinical Privileges

Mitral Regurgitation

Percutaneous mitral valve repair: current techniques and results

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA

7. Echocardiography Appropriate Use Criteria (by Indication)

AC Financial Services Reference Guide For Services referred to: Cardio Vascular Lab

Cardiac Resynchronization Therapy. Michelle Khoo, MD

Bioabsorbable Scaffolds: The Next Holy Grail?

Management of HOCM: Non-Surgical Options

Total Endovascular Repair Type A Dissection. Eric Herget Interventional Radiology

Il Cuore in Fortezza Savona, 9 Aprile 2015

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands

Holy Crap! Why is a Cardiologist Speaking at a GI Meeting? Jonathan A. Rapp, MD, FACC, FSCAI Cardiologist, Mercy Heart Institute Cincinnati, OH

Organic mitral regurgitation

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

Detailed Order Request Checklists for Cardiology

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

Bench Insights into Bifurcation Stenting in the DES Era: An Update

Recent Advances in Pacing and Defibrillation Harish Doppalapudi, MD

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

Leadless Pacing. Osama Diab Assistant Prof. of Cardiology Ain Shams University Egypt

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

IMAGING the AORTA. Mirvat Alasnag FACP, FSCAI, FSCCT, FASE June 1 st, 2011

Current status: Percutaneous mitral valve therapy

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

MitraClip World Wide Commercial Experience

Cleveland Clinic Innovation Center

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

What You Should Know About Subcutaneous and Transvenous ICD

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR

Minimally invasive therapies for the mitral valve: How will you incorporate into your clinical practice? Guilherme F.

Cardiac MRI in ACHD What We. ACHD Patients

Latest therapies for patients with HF. Dr AIGUL BALTABAEVA PhD, FESC, FRCP RBHT & ASPH

Drug eluting balloons in CAD

Disclosures. Update on Interventional Cardiology. Overview. In-stent restenosis (ISR) versus stent thrombosis (ST) No financial conflict of interest

Newer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity.

CARDIOLOGY. 3 To develop in the trainees the humanistic, moral and ethical aspects of medicine.

Personalized Care One Heart at a Time

Cardiac Computed Tomography

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

UNDERSTANDING TREATMENT OPTIONS FOR HEART DISEASE. Visit

Supplemental Material

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον. Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ

National Imaging Associates, Inc. Clinical guidelines CARDIAC CATHETERIZATION -LEFT HEART CATHETERIZATION. Original Date: October 2015 Page 1 of 5

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

INTERNAL MEDICINE SUBSPECIALTY CARDIOLOGY

New scientific documents from EHRA Management of patients with defibrillator shocks

British Cardiac Society. Clinical and laboratory cardiac facilities required in the UK

Percutaneous Valve Interventions. Percutaneous Valve Interventions

MR Advance Techniques. Cardiac Imaging. Class IV

Covered Indications. Evaluation of chest pain syndrome uninterpretable or equivocal stress test (exercise, perfusion, or stress echo)

Comprehensive Cardiology: Matters of the Heart Class III SARAH BEANLANDS RN BSCN MSC

CARDIAC MRI. Cardiovascular Disease. Cardiovascular Disease. Cardiovascular Disease. Overview

Next Generation Drug- eluting Stent : Will It Solve the Problem?

Working at Boston Scientific. Ronan Emmett Human Resources

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

SUPPLEMENTAL MATERIAL

New Generation Drug- Eluting Stent in Korea

Dr Chris Ellis. Consultant Cardiologist Auckland City Hospital Auckland. 11:30-12:00 ECGs for Nurses, and The Basics of CT Heart Scanning

AORTIC STENOSIS HENRY FORD HOSPITAL CENTER FOR STRUCTURAL HEART DISEASE

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

Percutaneous Therapy for Mitral Regurgitation: Current and Future Options: Could we do better today?

Transcription:

New joy of cardiac disease Coronary artery disease CT coronary angiography The bioabsorbable stent Valvular heart disease Percutaneous aortic valve replacement Mitral clip for mitral incompetence Arrhythmias 3-dimensional mapping MRI compatible pacemakers The subcutaneous implantable defibrillator Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, NZ

A Fully Bioabsorbable stents BVS everolimus-eluting stent Ormiston JA et al, Lancet 2008 Serruys PW et al, Lancet 2009 Ormiston JA Circulation Intervention 2009

Conventional metallic stents Limit restenosis by controlling intimal flaps, optimizing initial lumen size, preventing constrictive remodelling and delivering antiproliferative drug Radial support is needed to limit the negative remodelling for a few months Why have a permanent implant when a temporary can do the job?

Bioabsorbable stents may- Reduce late stent thrombosis and duration of DAT Restore normal vasomotion Facilitate re-intervention no jailed sidebranches or full metal jacket Allow non-invasive follow-up with MRI and CT Potential pediatric role Satisfy patient desire not to have permanent implant.

The BVS Everolimus-eluting eluting bioresorbable stent has Struts constructed from Poly-Lactic Acid Coating releases everolimus More uniform support and longer lasting radial support SEM Gen 1.0 Cohort A SEM Gen 1.1 Cohort B

Absorb. Serial changes on IVUS to 2 yrs Post-stenting 6 months 2 years 1. Vessel size (EEL) does not change (white) 2. Stent (broken line) shrinks 11% by 6 months then disappears 3. Lumen (blue) shrinks in area by 16% at 6 mo then increases

BL 6M 2Y OCT at baseline, 6 months and 2 yrs in Cohort A patient At 6 months there is a thin intimal layer, corrugated endolumen due to stent shrinkage and struts across a side-branch At 2 yrs the struts have largely disappeared, lumen has enlarged, endolumen nolonger 7 corrugated, and no side-branch jail

Cohort B patient- at 6 months there is no strut shrinkage Smooth endothelium,thin layer of intmal hyperplasia - Baseline 6 months The stent for Cohort B has longer lasting radial support so does not shrink by 6 months. It is likely to largely have disappeared by 2 yrs

Time will tell whether or not bioabsorbable stents represent a major breakthrough in treatment of coronary artery disease In 10 yrs we may look back and laugh at how we used to leave metal in coronary arteries

MitraClip percutaneous treatment of mitral regurgitation A major step in interventional cardiology To be introduced to Asia Pacific Region by Mercy Angiography this year (2010)

There is a current surgical technique with Edge-to-Edge Repair (Alfieri Stitch) for mitral regurgitation Accepted technique Over 900 reported in PRL Outcomes equivalent to standard of care surgical therapy Applicable to MR etiologies - Structural (Degenerative) - Functional

The anterior and posterior leaflets can be joined by a MitraClip mimicking the surgical suture

Catheter-Based Mitral Valve Repair MitraClip System 5 Investigational device limited by Federal (U.S.) law to investigational use only. PML02827 Rev. A 03/2010

The Everest II randomized trial of surgery vs MitraClip for mitral regurgitation showed that thet MitraClip was 1. Non-inferior for efficacy 2. Had a highly significant reduction in complications Feldman ACC 2010

The Subcutaneous Defibrillator From concept to reality Margaret Hood and Warren Smith

Evolving ICD Technologies 1985 1990 1995 2001 2008 Abdominal ICD Transvenous ICD Dual Chamber ICD CRT-D S-ICD

What does the S-ICDS ICD System not possess? No atrial or ventricular lead No long term pacing or CRT No ATP Unnecessary complexity

What does the S-ICDS see? Something like V 6 -V 1 NSR VT Surface ECG Intra-cardiac Cameron Health S-ECG

ICD Lead Performance Circulation 2008;117:2721-2723

DFT s reasonable and repeatable in the face of variable anatomy

ICD Penetration vs. Population at Risk ICD penetration Pool of prospective patients that might benefit from ICD Lowest risk pts amenable to ICD Rx (SCD-HeFT, MADIT II) General Population After Myerburg

1. Scout of Anatomy CTA Patients have 3 scans 2. Calcium Score 3. Main Scan

Multi-Slice CT (64 slice) ECG is gated ; requires slow and steady HR (50-70 bpm). Acquires a 3D data set of the whole heart, in 6-10 seconds 1 st heart beat 2 nd heart beat 3 rd heart beat 4 th heart beat 5 th heart beat

Calcified Coronary Arteries Intuitive for CVS Risk Look for disease! Concept used elsewhere Calcium Score Quantifies the density & degree in the coronaries Seems more logical than coloured charts

Relative Risk of Death (Unadjusted) Budoff et al 2007 JACC 70 60 50 RR of Death 40 30 20 10 0 Nil 1 to 10 11-100 101-299 300-399 400-699 700-999 Calcium Score (Agatston Units) >1000